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Summary 
African trypanosomes (Trypanosoma brucei spp.) are extracellular, hemoflagellate, protozoan 
parasites.  Mammalian infection begins when the tsetse fly vector injects trypanosomes into 
the skin during blood feeding.  The trypanosomes then reach the draining lymph nodes before 50 
disseminating systemically.  Intravital imaging of the skin post-tsetse fly bite revealed that 
trypanosomes were observed both extravascularly and intravascularly in the lymphatic vessels.  
Whether host-derived cues play a role in the attraction of the trypanosomes towards the 
lymphatic vessels to aid their dissemination from the site of infection is not known.  Since 
chemokines can mediate the attraction of leukocytes towards the lymphatics, in vitro 
chemotaxis assays were used to determine whether chemokines might also act as 
chemoattractants for trypanosomes.  Although microarray data suggested that the chemokines 
CCL8, CCL19, CCL21, CCL27 and CXCL12 were highly expressed in mouse skin, they did 
not stimulate the chemotaxis of T. brucei.  Certain chemokines also possess potent 
antimicrobial properties.  However, none of the chemokines tested exerted any parasiticidal 60 
effects on T. brucei.  Thus, our data suggest that host-derived chemokines do not act as 
chemoattractants for T. brucei.  Identification of the mechanisms used by trypanosomes to 
establish host infection will aid the development of novel approaches to block disease 
transmission.   
 
Key words: Trypanosoma brucei; skin, lymphatics; intravital imaging; chemokines; 
chemotaxis; cytotoxicity. 
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Introduction 
African trypanosomes are single-cell extracellular hemoflagellate protozoan parasites and are 70 
transmitted between mammalian hosts via blood-feeding tsetse flies of the genus Glossina.  
The Trypanosoma brucei rhodesiense and T. b. gambiense subspecies cause human African 
trypanosomiasis in endemic regions within the tsetse fly belt across sub-Saharan Africa. 
Animal African trypanosomiasis is caused by Trypanosoma congolense, Trypanosoma vivax 
and T. brucei and inflicts substantial economic strains on the African livestock industry.   
The parasitic life cycle within the mammalian host is initiated by the intradermal 
injection of metacyclic trypomastigotes by the tsetse fly vector.  The extracellular parasites 
then reach the draining lymph nodes, presumably via invasion of the afferent lymphatics and 
then disseminate systemically1, 2.  During this process the parasites also undergo morphological 
change into long slender bloodstream forms that are adapted for survival within the mammalian 80 
host.  Early studies showed that in both cattle and goats infected with T. vivax by tsetse fly bite, 
the parasites were detectable in the draining pre-scapular lymph nodes earlier than in peripheral 
blood during the initial period of infection3, 4.  This progression has also been replicated in 
mice2.  Following their intradermal injection by tsetse fly bite, T. brucei parasites were 
similarly first detected within the draining lymph nodes by 18 h, and subsequently detected in 
the blood by 42 h2.  These data raise the hypothesis that intradermally injected trypanosomes 
initially infect the local lymphatics within the skin before subsequently infecting the 
bloodstream and spreading systemically.  The currently licensed drugs that are available to treat 
trypanosomiasis have dangerous side-effects and drug-resistance is an increasing problem.  A 
fuller understanding of the mechanisms used by African trypanosomes to enable their systemic 90 
dissemination after infection would aid the development of novel approaches to block disease 
pathogenesis and transmission.   
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In the current study, intravital imaging revealed the novel finding that after injection 
into the skin African trypanosomes could be observed both extravascularly and intravascularly 
within the lymphatic vessels.  We therefore tested the hypothesis that host-derived cues such 
as chemokines may play a role in the attraction of the trypanosomes towards the lymphatic 
vessels to enable their dissemination from the site of infection.  Chemokines comprise a 
superfamily of 8-12 kDa globular proteins that play important roles in the attraction of 
lymphocytes and leukocytes towards the lymphatics and lymphoid tissues, and coordinate their 
positioning within them5, 6.  Chemokines mediate their activities through interactions with 100 
specific G protein-coupled chemokine receptors, which trigger intracellular pathways involved 
in cell motility and activation7.  For example, expression of the chemokines CCL19 and CCL21 
by local lymphatic endothelial cells mediates the homing of chemokine receptor CCR7 
expressing dendritic cells8.  In this study publicly-available microarray data sets were analysed 
to identify genes encoding chemokines that were highly expressed in mouse skin.   In vitro 
assays were then used to test the hypothesis that these host-derived chemokines may act as 
chemoattractants for T. brucei.   
In addition to their role in coordinating the chemotaxis and positioning of cells within 
tissues, many chemokines also possess potent antimicrobial properties, especially against 
certain pathogenic bacteria and fungi9-13.  These antimicrobial chemokines mediate their 110 
antimicrobial activities predominantly through the disruption and lysis of the pathogen cell 
membrane9.  Truncated variants of some CXC chemokines have also been reported to be 
directly bactericidal for Bacillus subtilis, Escherichia coli, Lactococcus lactis and 
Staphylococcus aureus, and fungicidal against Cryptococcus neoformans14.  The chemokine 
CCL28 has also been shown to have direct antimicrobial activity against bacteria and fungi, as 
well as direct parasiticidal effects against the protozoan parasite Leishmania mexicana15, a 
kinetoplastid protozoan related to T. brucei.  Therefore, in the current study in vitro assays 
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were also used to determine whether certain chemokines mediated any direct parasiticidal 
effects against T. brucei.   
 120 
 
Materials and Methods 
Trypanosomes 
In vitro cultivated monomorphic T. b. brucei Lister 427 strain trypanosomes, pleomorphic T. 
b. brucei STIB247 strain and T. b. brucei STIB247 trypanosomes16 expressing mCherry were 
used where indicated in this study.  Bloodstream-form Lister 427 parasites were axenically 
cultivated in vitro at 37°C in the presence of 5% CO2 as previously described17 using Iscoves 
modified Dulbecco’s medium supplemented with hypoxanthine (1.36 g/ml; Invitrogen), 
bathocuproinedisulphonic acid disodium salt (2.82 mg/ml; Sigma), thymidine (3.3 mg/ml, 
Sigma), sodium pyruvate (22 mg/ml, Sigma), L-cysteine (18.2 mg/ml, Sigma), β-130 
mercaptoethanol (0.2 mM, Invitrogen), kanamycin (10 mg/ml, Invitrogen), 
penicillin/streptomycin (100 U/ml, Invitrogen), 10% foetal bovine serum (Invitrogen) and 10% 
foetal bovine Serum-Plus (Sigma). Bloodstream-form STIB247 parasites were cultivated in a 
modified recipe of the above medium with the addition of glucose (100 mg/ml, Sigma), 
adenosine (13.4 mg/ml, Sigma), guanosine (14.2 mg/ml, Sigma), methylcellulose (110 mg/ml, 
Sigma), and 20% foetal bovine serum and 20% foetal bovine Serum-Plus.  
 
In vivo imaging 
All in vivo procedures were carried out at the University of Glasgow in accordance with United 
Kingdom Home Office regulations under the authority of the appropriate project and personal 140 
licenses.  Prox-1 mOrange mice18 were anesthetised using a freshly prepared 1:1 mixture of 
Hypnorm (25 mg/kg) and Hypnovel (12.5 mg/kg) injected intraperitoneally.  The hair on the 
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mouse ear to be imaged was removed by applying a hair removal cream (Nair) to the mouse 
ear for 2 mins, and then excess was removed with a damp tissue.  The mouse was then placed 
on a custom built imaging platform and core body temperature was continuously monitored by 
a rectal probe and maintained by a thermostatically controlled heat mat at 37°C.  The mouse 
ear was immobilised on the imaging platform using glue (3M Vetbond) which was set on the 
addition of phosphate buffered saline.  Prior to imaging, the mouse ear was injected 
intradermally with 10 µl containing 1 x 106 bloodstream form T. b. brucei STIB247 
trypanosomes expressing mCherry16.  Multiphoton imaging was performed using a Zeiss 150 
LSM7 MP system equipped with both a 10X/0.3 NA air and 20X/1.0NA water-immersion 
objective lens (Zeiss).  Two, fully tunable excitation wavelengths were produced by a 
Titanium/sapphire (Ti/S) solid-state 2-photon excitation source (Chameleon Ultra II; Coherent 
Laser Group), coupled to an optical parametric oscillator (OPO, Coherent Laser Group).  A 
Ti/S laser output of 820 nm and OPO signal of 1030 nm and 1090 nm provided excitation of 
mCherry and mOrange.  Images were acquired for approximately 15 - 20 mins and 3D tracking 
was performed using Volocity 6.1.1 (Perkin Elmer) and Imaris 7.6.5 software (Bitplane, 
Oxford Instruments).  Parasite turning angles were calculated using MATLAB software 
(Mathworks, version R2016b).  Images were collected from 5 individual mice and 2-3 fields 
of view/mouse.   160 
 
Microarray data  
The NCBI Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov) was searched 
for mouse skin expression data sets on the Affymetrix mouse genome 430 2.0 microarray 
platform.  Three independent studies which included normal, uninfected, wild-type mouse skin 
were publicly available (GSE17511, GSE7694, GSE27628) and the raw data sets (.cel files) 
were downloaded.  The quality of the raw data was analysed and normalised using Robust 
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Multichip Analysis (RMA EXPRESS; http://rmaexpress.bmbolstad.com/), and annotated 
using the library file available from Affymetrix (release 36, 13/4/16; 
http://www.affymetrix.com/).   170 
 
Chemotaxis assays 
All recombinant mouse chemokines used in this study were purchased from Peprotech 
(London, UK).  For chemotaxis assays, triplicate cultures were established as follows:  
Chemokines were suspended in the relevant trypanosome culture medium and 600 µl added to 
the corresponding wells of 24-well plates (Thermo Scientific).  Heat-inactivated chemokines 
(treatment at 95°C for 5 min.) or medium alone were used as negative controls.  A 3 µm trans-
well insert (Millipore Europe) was added to each well, and 1x106 trypanosomes in 100 µl media 
subsequently added to the upper chamber.  The plates were incubated for 2 h at 37°C in the 
presence of 5% CO2, and the number of trypanosomes that had passed through the trans-well 180 
insert pore into the lower chamber were counted in triplicate using an improved Neubauer 
haemocytometer.  Experiments were repeated three times.  Mouse splenocytes were also 
assessed as a positive chemotaxis control.  Splenocytes were isolated in fresh RPMI 1640 
media (5 ml of penicillin/streptomycin, 5 ml of L-glutamine and 0.1% fatty acid free BSA 
(Sigma-Aldrich) in 0.5 L of RPMI solution) by gently mashing them through a 70 µM cell 
EASYstrainer cell sieve (Greiner).  Next, 1x105 splenocytes suspended in 100 µL of media 
were added to the upper wells of 3 µM pore inserts (Millipore Europe), and 600 µL of 
chemokine-containing medium or RPMI 1640 medium was added to the bottom wells. The 
plates were incubated for 2 h at 37°C in the presence of 5% CO2, and the cells that had passed 
through the transwell insert pore into the lower chamber collected.  The cells were stained for 190 
FACS analysis using the following antibodies: anti-B220/CD45R-BV605 (RA3-6B2; 
Biolegend); anti-CD3-PB (145-2c11; Biolegend); and anti-CD11c-PE (N418; BD 
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Pharmingen).  Cells were acquired on a BD Fortessa LSR flow cytometer running FACSDiva 
and analysed using FlowJo 10.1 analysis software (FlowJo LLC).    
 To determine effects of chemokine treatment on trypanosome motility, T. brucei Lister 
427 parasites were treated with the chemokines CCL21, CCL27 and CCL28 or media alone as 
above at 37°C in the presence of 5% CO2 for 2 h.  The trypanosomes where then transferred to 
chambered slides (Lab-Tek Chambered Coverslip no. 1.5; Thermo Scientific), placed on a 
heated stage, and viewed using a Zeiss Axiovert 100 inverted microscope.  Videos of 
trypanosome motility in each condition (30 secs long, 50 frames/sec) were recorded using a 200 
Hamamatsu digital camera (Low-light, Hamamatsu Photonics) and Micro-manager 18.1.14 
imaging software (ImageJ plug-in, NIH).  Trypanosome motility in the videos was then 
subsequently analysed using Imaris 8.1.2 software (Bitplane, Oxford Instruments).  For each 
treatment condition data for 90 individual trypanosomes were collected (30 
trypanosomes/condition for each of 3 independent experiments).    
 
Cytotoxicity assays  
For cytotoxicity assays, triplicate cultures of 8 x105 trypanosomes in 100 µl medium were 
added to each well of a 96-well plate.  Chemokine-containing medium (200 µl/well) was then 
added to each well at a final concentration of 10, 100 or 500 ng/ml. Heat-inactivated 210 
chemokines (treatment at 95°C for 5 min.) or medium alone were used as controls.  The plates 
were incubated for 2 h at 37°C in the presence of 5% CO2, and the number of viable 
trypanosomes counted in triplicate using an improved Neubauer haemocytometer.    
Experiments were repeated three times.   
 
Membrane permeability assays 
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T. brucei Lister 427 trypanosomes were treated with 500 ng/ml of chemokines or 10 µM of the 
anti-trypanosome drug Berenil (diaminazine aceturate, as a positive control) in 100 µl of media 
for 2 h as described above. The parasites were then diluted 1:2 in PBS containing 4% propidium 
iodide (PI) and incubated in the dark for 30 minutes on ice. Uptake of PI into cells was then 220 
determined using a BD FACS Calibur cytometer and FlowJo 10.1 analysis software.    
Trypan blue-exclusion was used to determine the number of live or dead trypanosomes 
present following chemokine treatment.  Approximately 8 x105 trypanosomes in 100 µl 
medium were added to each well of a 96-well plate.  Chemokine-containing medium (200 
µl/well) was then added to each well at a final concentration of 500 ng/ml. The anti-
trypanosome drug Berenil was used as a control at concentrations of 1, 2 and 10 µM. The plates 
were incubated for 2 h at 37°C in the presence of 5% CO2.  Afterwards, the parasites were 
suspended in trypan blue dye and the number of live and dead trypanosomes counted using a 
haemocytometer.   
 230 
Transmission Electron Microscopy (TEM) 
To assess the impact of chemokine treatment on the morphological integrity of the parasites, 
monomorphic T. brucei Lister 427 trypanosomes were treated with chemokine-containing 
media (500 ng/ml), the trypanocidal drug Berenil (diminazine aceturate, 10 µM) as a positive 
control or medium alone as a negative control.  After 2 h of exposure the parasites were then 
processed for TEM imaging. Samples were washed in PBS to remove excess media and 
resuspended in 3% gluteraldehyde. Trypanosome pellets were then treated with 0.1 M sodium 
cacodylate buffer (pH 7.2) for 2 h, and washed three times for 10 mins in fresh 0.1 M sodium 
cacodylate buffer.  The samples were then post-fixed in 1% osmium tetroxide in 0.1 M sodium 
cacodylate for 45 mins and washed further three times for 10 mins in fresh 0.1 M sodium 240 
cacodylate buffer.  The samples were then dehydrated in increasing concentrations of ethanol 
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and subsequently treated with propylene oxide.  The samples were then embedded in TAAB 
812 resin (TAAB Laboratories Equipment Ltd), and sections (1 µm thick) stained with 
toluidine blue and viewed under a light microscope.  Ultra-thin sections (60 nm thick) were 
then cut from the areas of interest and stained in uranyl acetate and lead citrate for being 
analysed by TEM.   
 
Statistical analysis 
All data are derived from three independent experiments.  Statistical analyses were performed 
using GraphPad Prism 6.01 (Graphpad Software, Inc.).  Multiple comparisons between 250 
multiple groups from independent experiments were analysed using multi-way ANOVA with 
Tukey’s multiple comparisons test.  On each graph the individual replicates are shown, whereas 
the horizontal bar represents the mean ± SD.   
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Results 
Trypanosomes can be found in skin lymphatic vessels after intradermal injection 
A previous study in mice2 has shown that following the intradermal injection by tsetse fly bite, 
T. brucei parasites were first detected within the draining lymph nodes by 18 h and 260 
subsequently detected in the blood by 42 h.  This raised the hypothesis that trypanosomes 
initially infect the lymphatic vessels in the skin after intradermal injection to disseminate from 
the site of infection.  We used intravital imaging to visualise trypanosomes following injection 
into the skin.  T. brucei could be observed both extravascularly and intravascularly in the 
lymphatic vessels (Fig. 1A and Suppl. Movie 1). The trypanosomes detected within the 
lymphatics had a significantly higher velocity compared with extra-lymphatic parasites (Fig 
1B; P < 0.001).  The majority of extravascular parasites appeared to be moving non-randomly, 
towards or away from the lymphatic vessels as assessed by turning angle (turning angles 0° or 
180° respectively; (Fig. 1A, C & D), with individual parasites repeatedly moving towards, then 
away, then back again.  If static parasites were excluded from this analysis (those moving less 270 
than 5 µm between frames), this bimodal distribution was particularly clear (Fig. 1D). 
 
Chemokine gene expression in mouse skin 
Since trypanosomes were detected within lymphatic vessels after intradermal injection, we 
hypothesized that the parasites may be responsive to host-derived cues such as chemokines and 
use them to aid their dissemination from the site of infection.  We therefore compared the 
expression of chemokine-encoding genes in mouse skin using publicly available collections of 
microarray data.  Data from three independent studies were analysed (GEO accession codes: 
GSE17511; GSE7694; GSE27628) comprising a total of 11 individual microarrays (data sets) 
performed on the Affymetrix mouse genome 430 2.0 platform.  This analysis showed that genes 280 
encoding the chemokines CCL6, CCL8, CCL21, CCL27, CXCL12, CXCL14 and CXCL16 
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were expressed highly in the mouse back, ear and tail skin data sets (Fig. 2A,B).  Of these, the 
chemokines CCL8, CCL21, CCL27 and CXCL12 were selected for use in subsequent 
experiments, due to their high expression levels in the mouse skin regions.  We also included 
CCL19 since this chemokine, together with CCL21, also contributes to the homing of 
lymphocytes and leukocytes across the vascular endothelium8, 19. 
 
Effects of in vitro chemokine exposure on the chemotaxis and motility of T. brucei 
To determine whether certain chemokines may act as chemoattractants for T. brucei, standard 
chemotaxis assays were performed.  Monomorphic T. brucei Lister 427 trypanosomes were 290 
placed in the upper chamber of each well, which was separated from the lower chamber by a 3 
µm pore membrane.  Differing concentrations of each chemokine were then added to the 
medium in the lower chamber and the number of trypanosomes that had migrated into the lower 
chamber was determined 2 h later.  Heat-inactivated chemokines and medium alone were used 
as controls.  The chemokines CCL8, CCL19, CCL21, CCL27 and CXCL12 did not stimulate 
significant chemoattraction of T. brucei when compared to controls (Fig. 3).  This observation 
was not specific to the monomorphic T. brucei Lister 427 parasite strain since a parallel set of 
experiments showed that CCL21 also exerted no significant chemoattraction towards the 
pleomorphic T. brucei STIB 247 strain (Fig. 3F).  As anticipated, these chemokines mediated 
significant chemoattraction of mouse splenocytes (Suppl. Fig. 1).   300 
 We also assessed whether exposure to these chemokines might alter trypanosome 
motility characteristics.  The chemokine CCL21 was used in these studies due to its role in 
stimulating the homing of lymphocytes/leukocytes to lymphoid tissues and their migration 
across the vascular endothelium19.  Monomorphic T. brucei Lister 427 trypanosomes were 
incubated in medium containing CCL21 for 2 h and the motility of 90 individual parasites was 
recorded by live cell imaging.  Imaris software was then used to determine the effects of 
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treatment on trypanosome speed, as well as their velocities in the X and Y axes.  Consistent 
with data presented in Fig. 3, our analysis clearly showed that CCL21 exposure did not 
significantly affect trypanosome speed or velocity when compared to control-treated 
trypanosomes (Fig. 4).   310 
 
Effects of in vitro chemokine exposure on trypanosome viability 
As well as mediating the migration and position of certain host cell populations within tissues, 
some chemokines can display antimicrobial activities towards a range of microbial pathogens12, 
20-22.  We therefore determined whether chemokines might also exhibit direct parasiticidal 
effects.  Monomorphic T. brucei Lister 427 trypanosomes were incubated with differing 
concentrations of each chemokine and the number of viable trypanosomes determined 2 h later.  
In these experiments the chemokine CCL28 was also included since it had been shown in an 
independent study to exert potent antimicrobial effects towards bacteria and fungi21, 23 and the 
related protozoan parasite L. mexicana22.  Heat-inactivated chemokines and medium alone 320 
were used as controls.  Our data show that the viability of T. brucei was not significantly 
affected after in vitro exposure to CCL8, CCL19, CCL21, CCL27, CCL28 and CXCL12 (Fig. 
5).  As above, this was not specific to the monomorphic T. brucei Lister 427 strain of 
trypanosomes as CCL21 and CCL28 also exerted no significant effect on the pleomorphic T. 
brucei STIB 247 strain (Fig. 5G,H).   
 
Effects of in vitro chemokine exposure on membrane permeability and integrity 
Some chemokines have been shown to mediate their antimicrobial effects by causing direct 
damage to the plasma membranes of the target microorganism, including the protozoan parasite 
L. mexicana22.  We therefore determined whether the membrane integrity of chemokine-treated 330 
T. brucei parasites was affected by assessing their uptake of the vital dyes propidium iodide 
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(PI) and trypan blue.  Flow cytometry was used to determine the number of trypanosomes 
which were sufficiently permeabilized after treatment to allow entry of PI (Fig. 6A-C), whereas 
trypan blue-exclusion was used to compare the effects of treatment on the number of live or 
dead trypanosomes (Fig. 6D).  Trypanosomes exposed to medium alone were used as controls.  
When trypanosomes were treated with the trypanocidal drug Berenil (diminazine aceturate, as 
a positive control) membrane integrity and trypanosome viability was dramatically affected as 
anticipated (Fig. 6).  However, exposure to the chemokines CCL8, CCL19, CCL21, CCL27, 
CCL28 and CXCL12 had no significant effect on membrane integrity when compared to 
control-treated trypanosomes (Fig. 6).   340 
 Finally, TEM was used to determine whether chemokine exposure caused 
morphological damage to the plasma membranes of the trypanosomes.  As anticipated, 
substantial trypanosome destruction was observed following in vitro treatment with the 
trypanocidal drug Berenil (Fig. 7).  However, no observable effects on membrane integrity 
were observed following treatment with the chemokines CCL21, CCL27 or CCL28 when 
compared to control-treated trypanosomes (Fig. 7).   
 
 
Discussion 
Understanding the nature of and cues that trigger trypanosome movement in and 350 
between different tissue compartments is poorly understood, despite being critical to the 
progression of the parasite’s life cycle in the mammalian and insect hosts.  This aspect of 
trypanosome behaviour is of particular interest given recent studies that have described tissue-
specific populations (skin and adipose)2, 24, 25, highlighting gaps in our knowledge of where and 
how trypanosomes disseminate in the mammalian host.  Data in the current study show that 
following injection into the skin many of the trypanosomes could be observed migrating 
 16 
 
directly towards or away from the lymphatic vessels.  Furthermore, some of the trypanosomes 
were also detected within the afferent lymphatic vessels in the dermis.  These data are 
consistent with those in an independent study which has shown that following the intradermal 
injection of T. brucei parasites by tsetse fly bite, the parasites were first detected within the 360 
draining lymph nodes within hours of infection before their subsequent detection within the 
bloodstream2.  Leukocytes and lymphocytes are specifically attracted to lymphatic endothelial 
cells along chemokine gradients, and their interactions with specific adhesion molecules 
coordinate their adhesion to and migration across the endothelium26, 27.  Given that some 
trypanosomes were observed migrating within the lymphatics we hypothesised that the 
parasites may be responsive to host chemokines and use them to aid their dissemination from 
the site of infection.  However, our in vitro studies show that the chemokines CCL8, CCL19, 
CCL21, CCL27 and CXCL12 do not stimulate the chemotaxis or influence the motility of T. 
brucei.  This effect was evaluated using bloodstream forms of both monomorphic T. brucei 
427 and pleomorphic T. brucei 247 parasite.  Thus, our data suggests that the parasites are 370 
unlikely to use these chemokines as cues to aid their dissemination from the injection site in 
the skin.   
Data from elegant in vitro high-speed fluorescence microscopy studies have shown that 
the mode and dynamics of trypanosome locomotion can be influenced by the density of the 
surrounding matrix28.  In blood the trypanosomes display efficient forward motion28 and this 
appears important to help avoid immune mediated clearance29.  However, when the parasites 
become trapped, such as in a densely packed environment that resembles collagen networks or 
tissue spaces, the parasites reverse their flagellar beat and swim backwards28.  This apparent 
ability of the trypanosomes to adjust the beating direction of their flagellum in response to 
mechanical cues may help to explain the motility characteristics of the parasites that we 380 
observed following their injection into the skin.  Within the dermis the trypanosomes could be 
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visualised migrating towards and away from the lymphatics, with individual parasites 
repeatedly moving towards, then away, then back again.  Furthermore, the trypanosomes within 
the lymphatics had significantly faster velocity when compared to those in the extra-lymphatic 
environment.   
A recent study showed that there was a transient upregulation of the genes encoding 
CXCL1 and CXCL5 in the dermis of mice after bites from T. brucei infected tsetse flies30.  We 
did not test the effects of these chemokines on trypanosome motility or viability in the current 
study.  However, since these chemokines are typically produced by epithelial cells in response 
to damage to recruit cells such as neutrophils31, we consider they would be unlikely to 390 
contribute to the specific chemoattraction of trypanosomes towards lymphatic vessels.   
Infection in the mammalian host is initiated by the intradermal injection of metacyclic 
trypomastigotes by the tsetse fly vector.  While the precise timing is uncertain, these parasites 
then undergo morphological change into the long slender bloodstream forms that are adapted 
for survival within the mammalian host.  The chemotaxis studies utilized in vitro cultivated 
bloodstream trypanosome forms, thus it is plausible that the chemokines tested may differ in 
their activity against metacyclic forms.  However, an in silico protein-protein sequence 
comparison (NCBI BLAST search) found no matches for homologues of murine chemokine 
receptors in T. brucei genome data (data not shown).   
The endothelium of the collecting initial lymphatics typically has incomplete or absent 400 
intercellular junctions.  The loosely connected, overlapping borders of these lymphatic 
endothelial cells are considered to facilitate the unidirectional entry of tissue fluid and proteins 
into the lymphatics along hydrostatic pressure and protein gradients32, 33.  While it is plausible 
that African trypanosomes migrate towards the lymphatics by sensing lymph flow, this current 
is insufficient to push leukocytes such as classical dendritic cells towards the initial 
lymphatics27.   
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Batrachochytrium dendrobatidis is an important fungal pathogen of amphibians.  The 
zoospores of this pathogen have been shown to exhibit chemotaxis towards nutritional cues 
including sugars, proteins and amino acids34.  Within the mammalian host T. brucei derives its 
metabolic energy from blood glucose using a unique form of glycolysis35.  Since the 410 
concentration of glucose in the lymph has been shown to be higher than the bloodstream36, it 
is possible that glucose may act as a molecular cue for T. brucei following injection into the 
skin.   
Increasing evidence shows that many chemokines also possess potent antimicrobial 
properties against certain pathogens10.  All of the chemokines tested for parasiticidal activity 
in this study have been shown to demonstrate this activity: CCL8 and CCL19 are bactericidal 
against the Gram-negative bacterium E. coli11; CCL21 is bactericidal against E. coli and the 
Gram-positive bacterium S. aureus11; CCL27 has fungicidal activity against Candida 
albicans23; and CXCL12 is bactericidal against S. aureus and the E. coli11.  The chemokine 
CCL28 was of particular interest since it has been shown to exert broad-spectrum antimicrobial 420 
effects towards Gram-positive bacteria and Gram-negative bacteria21, 23, fungicidal activity 
towards C. albicans23 and parasiticidal activity towards the protozoan parasite L. mexicana22.  
However, none of the chemokines tested in the current study exerted any observable 
parasiticidal effects towards T. brucei.  Many of these antimicrobial chemokines mediate their 
activities through the disruption and lysis of the pathogen cell membrane10.  However, in our 
studies the membrane integrity of T. brucei was not adversely affected after chemokine 
exposure.  The human chemokines CXCL2, CXCL6, CXCL9, CXCL10, CCL20 and CCL28 
have been shown to exert their parasiticidal effects against L. mexicana by adversely affecting 
mitochondrial activity15.  However, a similar mode of action against bloodstream T. brucei is 
unlikely since this life cycle stage lacks significant mitochondrial function37.  Although the 430 
above Leishmania study investigated the effects of chemokines on the promastigote forms of 
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parasite which share similar dimensions, flagellar motility and extracellular niche to that of T. 
brucei, it is plausible that antimicrobial chemokines may be more effective against intracellular 
pathogens.  Within cells the intracellular chemokine concentrations may be much higher, or 
the chemokine may disturb the intracellular niches in which the pathogens reside.  For example, 
human CXCL4 can kill erythrocyte-inhabiting Plasmodium falciparum parasites by selectively 
lysing the parasitic digestive vacuole38. 
Together, our data show that following injection into the skin some of the trypanosomes 
could be observed migrating intravascularly within the afferent lymphatic vessels in the dermis.  
However, the cues that the trypanosomes might exploit to enable them to infect the lymphatic 440 
vessels are not known.  Identification of the mechanisms used by African trypanosomes to 
establish host infection after intradermal injection into the skin would aid the development of 
novel prophylactic approaches to block their systemic dissemination in the mammalian host 
and reduce disease transmission.   
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FIGURE 1  Intravital imaging shows T. brucei could be observed both extravascularly and 
intravascularly in the lymphatic vessels after injection into the skin.  (A) Still images from 
Supplementary Movie 1 show T. brucei parasites (red) present adjacent to and within lymphatic 
vessels (white) in the skin of Prox1 mOrange reporter mice.  (B) Analysis of parasite velocities 
in Supplementary Movie 1 revealed that intravascular parasites displayed greater speed of 
movement compared with extravascular parasites.  ***, P < 0.001.  Furthermore, parasites 
adjacent to lymphatic vessels displayed directional movement towards or away from lymphatic 
vessels (identified by arrows in (A) and parasite tracking data (C)).  (D) Analysis of parasite 
tracks in panel C and Supplementary Movie 1 confirmed that the parasites had a bimodal 550 
distribution of turning angles, suggesting directional movement in the skin.  Exclusion of static 
parasites from the analysis (red line) made this conclusion more evident.  Scale bars, 50 µm.  
White broken lines in A and C outline the lymphatic vessels.  Images and movie are 
representative of 5 mice and 2-3 fields of view/mouse.    
 
FIGURE 2  Retrospective comparison of chemokine gene expression in mouse skin. Heat 
maps show the expression of profile of multiple CCL (A) or CXCL (B) chemokine-encoding 
probe sets in the samples of back, ear and tail skin (GEO accession codes: GSE17511; 
GSE7694; GSE27628).  These data were performed on Affymetrix MOE430_2 mouse genome 
expression arrays (Affymetrix, Santa Clara, CA). Each column represents the mean probe set 560 
intensity (log2) for individual data sets (samples) from each source.  Representative probe set 
are shown when multiple probe sets for a gene were present on the arrays. 
 
FIGURE 3  Effect of in vitro chemokine exposure on trypanosome chemotaxis. 1 x 106 viable 
monomorphic T. brucei Lister 427 trypanosomes (A-E) or pleomorphic T. brucei STIB 247 
trypanosomes (F) were placed in the upper chamber of each well which was separated from 
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the lower chamber by a 3 µm pore membrane.  The respective concentration of (A) CCL8, (B) 
CCL19, (C,F) CCL21, (D) CCL27 and (E) CXCL12 were then added to the medium in the 
lower chamber and the number of trypanosomes which had migrated into the lower chamber 
determined 2 h later.  Heat-inactivated chemokine (i500, i100) or medium alone were used as 570 
negative controls.  Each point represents the mean from triplicate wells, the horizontal bar 
represents the mean ± SD.  All experiments were repeated three times on different days.   
 
FIGURE 4  Effect of in vitro CCL21 exposure on trypanosome motility.  Monomorphic T. 
brucei Lister 427 trypanosomes were incubated in medium containing CCL21 for 2 h and the 
motility of 90 individual parasites recorded by live cell imaging.  Imaris software was then 
used to determine the effects of treatment on trypanosome speed, as well as their velocities in 
the X and Y axes.  Each point represents data from the analysis of individual trypanosomes, 
the horizontal bar represents the mean ± SD.   
 580 
FIGURE 5 Effect of in vitro chemokine exposure on trypanosome viability.  Viable 
monomorphic T. b. brucei Lister 427 trypanosomes (A-F) or pleiomorphic T. brucei STIB 247 
trypanosomes (G,H) (8 x 105/1 ml well) were incubated in medium containing differing 
concentrations of (A) CCL8, (B) CCL19, (C,G) CCL21, (D) CCL27, (E) CXCL12 and (F,H) 
CCL28 were then added to the medium and the number of viable trypanosomes determined 2 
h later.  Heat-inactivated chemokine (i500, i100, i10) or medium alone were used as control.  
Each point represents the mean from triplicate wells, the horizontal bar represents the mean ± 
SD.  All experiments were repeated three times on different days. 
 
FIGURE 6 Effect of in vitro chemokine exposure on trypanosome membrane permeability 590 
and viability.  (A) Flow cytometric analysis of PI-uptake by trypanosomes after chemokine 
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exposure.  T. brucei Lister 427 trypanosomes were exposed for 2 h to 500 ng/ml of CCL21, 
CCL27 or CCL28, or 10 µM of the anti-trypanosome drug Berenil (diminazene aceturate) 
before analysis.  The percentage PI-positive cells in the gated regions of each scatter plot are 
shown.  (B) Histoplot shows the relative cell count vs. PI uptake following exposure of T. 
brucei Lister 427 trypanosomes to medium alone (control, red), CCL21 (light blue), CCL27 
(dark blue), CCL28 (green) or Berenil (shaded).  (C) Histogram shows the % PI-positive 
trypanosomes following in vitro exposure to chemokines or the trypanocidal drug Berenil.  
Each bar represents the mean from three independent experiments ± SD.  (D) Histogram shows 
the percentage live and dead trypanosomes after exposure to chemokines or the anti-600 
trypanosome drug Berenil.  All experiments were repeated three times on different days. 
 
FIGURE 7 TEM analysis shows in vitro chemokine exposure does not adversely affect 
trypanosome morphology.  T. brucei Lister 427 trypanosomes were exposed to medium alone 
(control), or CCL21, CCL27 or CCL28 (500 ng/ml), or the anti-trypanosome drug Berenil 
(diminazene aceturate, 10 µM) for 2 h before analysis.  Whereas substantial parasite destruction 
was observed following Berenil treatment, no observable effects on membrane integrity were 
observed after chemokine treatment.   
 
SUPPLEMENTARY VIDEO 1 Intravital imaging shows that after their injection into the 610 
skin, T. brucei parasites adjacent to lymphatic vessels display directional movement towards 
or away from the lymphatic vessels.  T. brucei parasites (red) could be observed both 
extravascularly and intravascularly in the lymphatic vessels (white) after injection into the skin 
of Prox1 mOrange reporter mice.  
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SUPPLEMENTARY FIGURE 1  Effect of in vitro chemokine exposure on the chemotaxis 
of mouse splenocytes.  Cells (1 x 106) were placed in the upper chamber of each well which 
was separated from the lower chamber by a 3 µm pore membrane.  The chemokines CCL8, 
CCL19, CCL21, CCL27 and CXCL12 were then added to the medium in the lower chamber 
at a concentration of either 100 or 500 ng/ml and the number of cells which had migrated into 620 
the lower chamber determined 2 h later by flow cytometry.  Foetal bovine serum (FBS) or 
medium alone were used as negative controls.  Each point represents the mean from triplicate 
wells, the horizontal bar represents the mean ± SD.  All experiments were repeated three times 
on different days.  *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
 
 
 
 
 
 
 
 
 
 
